Correlation Between SAB Biotherapeutics and Alx Oncology

Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Alx Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Alx Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SAB Biotherapeutics and Alx Oncology Holdings, you can compare the effects of market volatilities on SAB Biotherapeutics and Alx Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Alx Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Alx Oncology.

Diversification Opportunities for SAB Biotherapeutics and Alx Oncology

-0.68

Correlation Coefficient

SAB Biotherapeutics  Alx Oncology

Excellent diversification

The 3 months correlation between SAB and Alx is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Alx Oncology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alx Oncology Holdings and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Alx Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alx Oncology Holdings has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Alx Oncology go up and down completely randomly.

Pair Corralation between SAB Biotherapeutics and Alx Oncology

Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 29.11 times more return on investment than Alx Oncology. However, SAB Biotherapeutics is 29.11 times more volatile than Alx Oncology Holdings. It trades about 0.14 of its potential returns per unit of risk. Alx Oncology Holdings is currently generating about -0.05 per unit of risk. If you would invest  2.60  in SAB Biotherapeutics on September 4, 2024 and sell it today you would earn a total of  2.57  from holding SAB Biotherapeutics or generate 98.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	85.94%
Values	Daily Returns

SAB Biotherapeutics  vs.  Alx Oncology Holdings

SAB Biotherapeutics

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in SAB Biotherapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, SAB Biotherapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Alx Oncology Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Alx Oncology Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with SAB Biotherapeutics and Alx Oncology

The main advantage of trading using opposite SAB Biotherapeutics and Alx Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Alx Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alx Oncology will offset losses from the drop in Alx Oncology's long position.

The idea behind SAB Biotherapeutics and Alx Oncology Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.